THE INVOLVEMENT OF CALCITONIN-GENE-RELATED PEPTIDE (CGRP) AND SUBSTANCE-P IN FELINE PIAL ARTERY DIAMETER RESPONSES EVOKED BY CAPSAICIN

被引:20
作者
ESCOTT, KJ
CONNOR, HE
BRAIN, SD
BEATTIE, DT
机构
[1] UNIV LONDON KINGS COLL,VASC BIOL RES CTR,LONDON SW3 6LX,ENGLAND
[2] GLAXO RES & DEV LTD,PHARMACOL 2,WARE,HERTS,ENGLAND
关键词
D O I
10.1016/0143-4179(95)90014-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of capsaicin and selective neuropeptide antagonists on pial artery diameter were measured using an on-line image analyser in anaesthetised cats, in order to monitor the effects of mediators released in response to activation of trigeminal nerves. Perivascular injection of CGRP (10(-8) M) and the neurokinin-1 (NK1) receptor agonist substance P methyl ester, SPOMe (10(-6) M) produced an increase in pial artery diameter. The vasodilatory action of these agonists was significantly and selectively inhibited using the CGRP receptor antagonist, CGRP(8-37) (10(-6) M), and the NK1 receptor antagonist, CP99994 (10(-6) M) respectively. Capsaicin (10(-8)-10(-5) M) produced a biphasic response upon perivascular injection that was concentration dependent. At 10(-6) M capsaicin an initial transient vasoconstriction was observed followed by a longer-lasting vasodilatation. The vasodilator component was significantly reduced by CGRP(8-37) (10(-6) M) or CP99994 (10(-6) M). These results show that chemical (capsaicin) activation of trigeminal nerves leads to vasodilatation of feline arteries in situ. This vasodilatation is mediated via the activation of CGRP and NK1 receptors probably via the efferent release of CGRP and a substance P-like peptide.
引用
收藏
页码:129 / 135
页数:7
相关论文
共 22 条
[1]  
AMANN R, 1991, LIFE SCI, V49, P89
[2]   NEUROKININ-INDUCED CHANGES IN PIAL ARTERY DIAMETER IN THE ANESTHETIZED GUINEA-PIG [J].
BEATTIE, DT ;
STUBBS, CM ;
CONNOR, HE ;
FENIUK, W .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (01) :146-149
[3]  
BEVAN S, 1990, TRENDS PHARMACOL SCI, V11, P330
[4]   CALCITONIN GENE-RELATED PEPTIDE RECEPTOR ANTAGONIST HUMAN CGRP-(8-37) [J].
CHIBA, T ;
YAMAGUCHI, A ;
YAMATANI, T ;
NAKAMURA, A ;
MORISHITA, T ;
INUI, T ;
FUKASE, M ;
NODA, T ;
FUJITA, T .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (02) :E331-E335
[5]   NEUROKININ-A IN CEREBRAL VESSELS - CHARACTERIZATION, LOCALIZATION AND EFFECTS INVITRO [J].
EDVINSSON, L ;
BRODIN, E ;
JANSEN, I ;
UDDMAN, R .
REGULATORY PEPTIDES, 1988, 20 (03) :181-197
[6]   CEREBROVASCULAR RESPONSES TO CAPSAICIN INVITRO AND INSITU [J].
EDVINSSON, L ;
JANSEN, I ;
KINGMAN, TA ;
MCCULLOCH, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 100 (02) :312-318
[7]   EFFECT OF A CALCITONIN-GENE-RELATED PEPTIDE ANTAGONIST (CGRP8-37) ON SKIN VASODILATATION AND EDEMA INDUCED BY STIMULATION OF THE RAT SAPHENOUS NERVE [J].
ESCOTT, KJ ;
BRAIN, SD .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (02) :772-776
[8]  
ESCOTT KJ, IN PRESS BRAIN RES
[9]   RELEASE OF VASOACTIVE PEPTIDES IN THE EXTRACEREBRAL CIRCULATION OF HUMANS AND THE CAT DURING ACTIVATION OF THE TRIGEMINOVASCULAR SYSTEM [J].
GOADSBY, PJ ;
EDVINSSON, L ;
EKMAN, R .
ANNALS OF NEUROLOGY, 1988, 23 (02) :193-196
[10]   TACHYKININ RECEPTOR TYPES - CLASSIFICATION AND MEMBRANE SIGNALING MECHANISMS [J].
GUARD, S ;
WATSON, SP .
NEUROCHEMISTRY INTERNATIONAL, 1991, 18 (02) :149-165